Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00869_DB01194_nanopub.RAIpcJc6G7smef_TvZyqrqczpnlRxjuDXhnBcp7LbTWKY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00869_DB01194 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00869_DB01194 label "DDI between Dorzolamide and Brinzolamide - As both brinzolamide and dorzolamide are carbonic anhydrase inhibitors, there is an increased risk of adverse effects.The development of acid-base disorders with concurrent use of ophthalmic and oral carbonic anhydrase inhibitors has been reported. Avoid concurrent use of different carbonic anhydrase inhibitors when possible. [drugbank_resource:DB00869_DB01194]" assertion.
- drugbank_resource:DB00869_DB01194 identifier "drugbank_resource:DB00869_DB01194" assertion.
- drugbank_resource:DB00869_DB01194 title "DDI between Dorzolamide and Brinzolamide - As both brinzolamide and dorzolamide are carbonic anhydrase inhibitors, there is an increased risk of adverse effects.The development of acid-base disorders with concurrent use of ophthalmic and oral carbonic anhydrase inhibitors has been reported. Avoid concurrent use of different carbonic anhydrase inhibitors when possible." assertion.
- drugbank:DB00869 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00869_DB01194 assertion.
- drugbank:DB01194 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00869_DB01194 assertion.